FDA Grants Breakthrough Status for Staph Infection Treatment

A new bacteria-fighting treatment just earned FDA breakthrough status for drug-resistant staph bloodstream infections.

The phage therapy will move to Phase 3 trials, offering hope for patients who've run out of antibiotic options.